| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.041 | 0.5 |